For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
About this episode
The episode discusses advancements in the treatment of non-muscle-invasive and muscle-invasive bladder cancer, featuring expert insights from various oncology professionals.
Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics: Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00) Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35) Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13) Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55) Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20) NCPD information and select publications
More episodes of Prostate Cancer Update
- Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
- Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
- Prostate Cancer — Fifth Annual National General Medical Oncology Summit
- Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
- Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.